GI
GOSS icon

GAMMA Investing’s Gossamer Bio GOSS Stock Holding History

GAMMA Investing’s Portfolio GOSS Stock Details GOSS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$206 Buy
+1,250
New +$349 ﹤0.01% 4091
2026
Q1 		– Sell
-468
Closed -$1.45K – 4170
2025
Q4 		$1.45K Buy
+468
New +$1.33K ﹤0.01% 3695

Other funds holding GOSS

D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
6CM
683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return
DIG
DeepCurrents Investment Group New York $3.3B AUM 12.57% 1-Year Est. Return
CCM
Context Capital Management Lajolla, California $5.15B AUM 1.28% 1-Year Est. Return
WVP
Worth Venture Partners Fort Lee, New Jersey $44.3M AUM 34.55% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return
WAM
Wolverine Asset Management Chicago, Illinois $11.4B AUM 5.65% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
KCM
Kalehua Capital Management Dallas, Texas $174M AUM

GAMMA Investing's GOSS Position: Q2 2026 in Review

GAMMA Investing opened a new position in Gossamer Bio (GOSS) in Q2 2026: 1,250 shares worth $206. The stake represents ﹤0.01% of the portfolio and ranks #4091 among its holdings. This is a return to the name: GAMMA Investing previously reported a position in GOSS as recently as Q4 2025.

GAMMA Investing first reported a position in GOSS in Q4 2025 and has held it in 2 quarters since. The position peaked at $1.45K in Q4 2025. 170 funds tracked by Wall St. Rank hold GOSS as of Q2 2026.

  • GAMMA Investing held 1,250 shares of Gossamer Bio worth $206 as of Q2 2026.
  • Gossamer Bio was a new GAMMA Investing position in Q2 2026.
  • Gossamer Bio made up ﹤0.01% of GAMMA Investing's portfolio in Q2 2026, its #4091 holding.
  • GAMMA Investing first reported a position in Gossamer Bio in Q4 2025 and has held it in 2 quarters since.
  • GAMMA Investing's Gossamer Bio position peaked at $1.45K in Q4 2025.
  • 170 funds tracked by Wall St. Rank held Gossamer Bio as of Q2 2026.

Based on GAMMA Investing's 13F filing for Q2 2026, filed 7 Jul 2026.